Oral Wegovy (Semaglutide Pill) December 2025 saw the approval of the Wegovy pill, offering a daily oral alternative for weight management
Many skin issues like hyperpigmentation or acne cause it to become inflamed
They improve insulin sensitivity and stabilize blood sugar
Today, theyve become the cornerstone of modern diabetes treatment, and not just because they control glucose effectively
doi: 10.3389/fimmu.2023.1148209 Received 19 January 2023 Accepted 26 April 2023 Published 17 May 2023 Volume 14 - 2023 Edited by Christoph Thiemermann, Queen Mary University of London, United Kingdom Reviewed by Marcin Filip Osuchowski, Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Austria
And the government needs to intervene, requiring Medicare to treat obesity as a chronic condition and initiating coverage for Part D enrollees who are prescribed a GIP or GLP-1 medication solely for the treatment of weight loss, rather than restricting coverage to those with diabetes or cardiovascular disease